SESN2 and early-onset autosomal dominant Alzheimer disease: Rai et al. [26] and Kamalzadeh et al. [27] also showed significantly increased serum SESN2 levels in patients with Parkinson's disease and Alzheimer's disease, with a significant negative correlation to mental and cognitive function.